(Total Views: 648)
Posted On: 09/24/2020 9:09:33 AM
Post# of 155592
You have no idea how helpful that comment is.
So far we are not better than Remdesivir ( not enough data/patients). NP can tell us how much money he raised in the past another twenty times but his most recent Fife deal sucks. Wouldn't we have been better off doing a raise at $3/share instead of what we have which is a high fee/interest loan that will likely lead to substantial dilution at a far lower than $10/share? Why did he deal with Fife again? To make people think CYDY was going to $10 or $20 or triple digits before the end of the term?
We need management to start thinking in new ways. Better communication (not more). Better governance. Better partnering.
So far we are not better than Remdesivir ( not enough data/patients). NP can tell us how much money he raised in the past another twenty times but his most recent Fife deal sucks. Wouldn't we have been better off doing a raise at $3/share instead of what we have which is a high fee/interest loan that will likely lead to substantial dilution at a far lower than $10/share? Why did he deal with Fife again? To make people think CYDY was going to $10 or $20 or triple digits before the end of the term?
We need management to start thinking in new ways. Better communication (not more). Better governance. Better partnering.
(4)
(2)
